Stock Latest News Best Industries To Invest In For 2021 And Make MoneyMay 5, 20222021 is now upon us and with it brings many great opportunities for investing. Here’s our top 5 best industries to invest in for 2021. 1. Artificial Intelligence Firstly, there’s a reason why it feels like everyone is talking about Artificial Intelligence (A.I.). AI has steadily been implemented more and more into our society as it continues to advance. With rapidly growing technology, usually there is money to be made as well and A.I. is no exception. Big tech giants like Google (NASDAQ: GOOGL), Nvidia (NASDAQ: NVDA), Facebook (NASDAQ: FB), and many more are all aggressively pursuing AI. According to the International Data Corporation (IDC): “spending on A.I. systems will reach $97.9 billion in 2023, more than two and one half times the $37.5 billion that will be spent in 2019″. Not only on a company scale is there competition for the development of A.I., but there is heavy international competition as well. The United States is spending billions of dollars on their defense project, AI Next. Meanwhile, one Chinese state alone have spent over $5 billion on the development of artificial intelligence. China plans to be the leader of the $150 billion dollar industry by 2030. As in investor, you may be curious how you can get a slice of the pie. The most effective way would be to invest in individual companies that may lead in the space like Nvidia or Alteryx (NYSE: AYX). However, the most surefire way would be to invest in a strong A.I. ETF like the Global X Robotics & Artificial Intelligence (NASDAQ: BOTZ) fund. Overall, this industry is still at the cusp of its growth and it’s hard to say when exactly it will completely takeoff. Alternatively, when it does take off, many investors will reap very significant gains from their A.I. investments. 2. U.S. Marijuana Next, marijuana stocks are steadily been on the rise and will continue to rise as legalization sweeps across the United States. Currently, 14 states have fully legalized marijuana and several others have legalized it partially. The next candidates to legalize are Connecticut, New York, Rhode Island, and Virginia. A nation-wide legalization is very probable as well. Also, as of January fifth, the democrats officially control the Senate, the House of Representatives, and the presidency. Democratic legislation is extremely easy to pass now as a result. It should come as no surprise if we see legalization occur as soon as 2022. The boat is being loaded for many cannabis stocks in hopes of further legalization. Moreover, you may be wondering how profitable the marijuana industry will truly be. The U.S. marijuana industry will generate as much as $85 billion in sales in 2030, according to Cowen analyst Vivien Azer. Holders of stocks that become industry leaders and get a large portion of this market cap will be greatly rewarded. There’s many companies competing for a spot in this industry. One of the most popular contenders Aurora Cannabis (NYSE: ACB) which currently sits on a market cap of $1.93 billion dollars. Additionally, some smaller companies that we see as long-term winners are Planet 13 (OTCMKTS: PLNHF) and Clever Leaves (NASDAQ: CLVR). Furthermore, there’s many ETFs for cannabis for a wider range of marijuana stocks like ETFMG Alternative Harvest (NYSEARCA: MJ). This industry may boom faster than you expect and chances are it’s in your benefit to get in now. 3. Plant-Based Foods Thirdly, plant-based foods is easily one of the best industries to invest in for 2021. Veganism is taking the world by storm as society is becoming more health and environmentally conscious. Companies like Beyond Meat (NASDAQ: BYND) and Impossible Foods are at the forefront and are rapidly spreading across the United States. There has been over a 300% increase in people who identify as vegans in the United States over the past 15 years and that number is growing. With this growing demand, vegan companies are generating revenues from recurring customers faster than ever before. Consequently, this is incentivizing them to expand faster and invest further into themselves. Studies have revealed the undesirable effects that can occur with consuming meat which is further pushing vegan agenda. Right now, Beyond Meat appears to be the market leader and is rumored to soon have a deal with McDonalds underway. This deal will not only bring in very nice revenues for Beyond Meat, but it will greatly spread their brand recognition as well. Some smaller players in the market are Tattooed Chef (NASDAQ: TTCF) and The Very Good Food Company (OTCMKTS: VRYYF). Tattooed Chef plans to spend a very hefty amount of money on advertising this year and introduce more products. Alternatively, The Very Good Food Company is still in earlier stages and is currently listed on the OTC Market. 4. Energy Storage/Renewable Energy Further, energy storage and renewable energy are going to be very hot sectors this year. Biden has made it clear that renewable energy is one of his top priorities and he plans to spend significant money to bolster the industry. We are becoming more and more environmentally conscious as our awareness on how we impact the world is sharply increasing. The new Democratic wave of government will fund and most likely pass legislation to help renewable energy companies take off. We have seen companies in the past, like Enphase Energy (NASDAQ: ENPH) take off and continue to rise as they provide new environmentally sustainable technologies for our future. Consequently, either investing in existing, successful energy companies or investing in new innovative ones nearly certainly promises significant gains. Our all-encompassing play for this industry would be the ETF Brookfield Renewable Partners LP (NYSE: BEP). Also, Star Peak Energy Transition Corp (NYSE: STPK) is soon to merge with Stem, Inc. Star Peak Energy Transition Corp is very promising, but has increased risk. 5. Genomics Next up, genomics is often forgotten when shopping for stocks, but this sector has already started to boom and it’s only the beginning. The likelihood for an individual to get cancer in their lifetime is over 30% and it ranks as one of the top causes of death. Cancer is rapidly being researched and treatments are aggressively being developed. Due to the complexity of the issue, progress has been apparent, but very slow. Crispr Therapeutics (NASDAQ: CRSP), Illumina (NASDAQ: ILMN), and Genomic Health (NASDAQ: GHDX) have all been been strong, growing genomic companies. Just by 2027, the industry is expected to grow to $31.1 Billion with a CAGR of 7.7% according to Grand View Research. These numbers could easily be considered conservative as well with how hot the industry is right now. One of the best investments for the genomic industry is the Ark’s genomic ETF: ARK Genomic Revolution ETF (BATS: ARKG). This ETF has grown over 150% annually and is actively managed by a great team. Genomics clearly has potential and as a result has earned itself a spot in the top 6 industries to invest for 2021. 6. Electric Vehicles Finally, electric vehicles are a very nice place to put your money in 2021 and watch it grow. This sector has certainly been one of the hottest areas in 2020 and it’s likely that the attention has been for good reason. CAGR are expected to be as high as 29% with increasing demand and rapid innovation. Tesla (NASDAQ: TSLA) has been on the forefront of this revolution led by Elon Musk who is now the richest man in the world due to Tesla Stock. Nio (NYSE: NIO), often claimed to be the “Chinese Tesla”, is in pursuit of Tesla with plans to release a sedan in late 2022. By 2030, 50% of China’s vehicles are expected to electric powered and 30% of United States are predicted to be electric. Furthermore, these number can easily be higher with people accepting electric powered vehicles faster than ever. Currently, Tesla is more on the risky side. It may have a profitable future, but right now is not the ideal time to get in. If you are looking to get in a position in Tesla, it would most likely be in your best interest to wait until it has a correction. Alternatively, some stocks that will benefit from this industry are ChargePoint (NYSE: CHPT) and XL Fleet (NYSE: XL). Switchback Energy plans to merge with Charge Point who have the largest ownership of charging stations in the United States. Meanwhile, XL Fleet’s business model is different in that they turn gas powered vehicles into electric vehicles. They do not sell their service commercially yet, but once they do there are almost certain revenues to be made. Best Industries To Invest In For 2021: Conclusion In summary, 2021 is predicted to be another profitable year for many investors. There are many different profitable industries to choose from and beat the market. These 6 industries are definitely some of the best industries to invest for 2021 and beyond. By researching the best stocks to invest in, you can beat the market and have very admirable gains.... Read more...Is Tesla Stock a Buy?May 5, 2022Coming Soon..... Read more...AONE Stock Forecast: A Hidden Gem (Markforged)May 5, 2022Shares of AONE were up over 30% earlier this year, but are now sitting below their initial offering price at $10.11. Here’s my AONE stock forecast and why this might be a hidden diamond. What Is AONE? First off, it’s important to know what AONE (NYSE: AONE) is. AONE is a San Fransisco-based SPAC (Special Acquisition Company) that is set to acquire Markforged this summer. Markforged is an A.I. powered 3D printing, industrial manufacturer that uses complex software. Markforged brings cutting edge technology to help modern manufacturers function as efficient as possible. They focus on reducing both massive amounts of time and costs of production by implementing their systems. Additionally, AONE is set to reverse-merge on the NYSE market under the ticker “MKFG”. The valuation is expected to be somewhere between 2-3 billion. Markforged is no new company. They’ve been developing for over 8 years, refining their softwares/components and have finally decided to join the market. Their timing, however, couldn’t be worse. SPACs are currently at all time lows after facing heavy scrutiny. There has been a great rotation from speculative, growth stocks to large-cap, trusted stocks recently. AONE has been no exception to this rotation and has lost all of its momentum since its October IPO (Initial Public Offering). Despite its recent price movement, Cathie Wood of ARK Invest has been heavily buying 3D disruptors and recently started purchasing AONE. Investors can be confident knowing that Markforged is not untrustworthy or extremely speculative. On the bright side, AONE has most likely gone through the worst of the SPAC disdain already. Hopefully by the time their merger takes place, SPAC trust has once again started to solidify. Either way, investors who plan to invest in Markforged now have a great entry point if they did choose to get in before the merger. Growth And Expansion Of Markforged First, it’s important to mention just how applicable Markforged is to the real world in general. Markforged intends to disrupt the industrial automation, aerospace, defense, automotive, medical, and space exploration industries. Anywhere that requires world class levels of refinement can benefit from Markforged. Additionally, Markforge’s software grows with each application. The A.I. driven software learns and improves as it continues to be applied. The more contracts and use of Markforged software, the more efficient and refined it will become. Markforged currently has over 170 issued/pending patents for their software and utilities. They are an innovative disruptor in an exponentially growing industry and are preventing replication as well. Currently, Markforged just hit $70 million in revenue for year 2020. They expect this to grow 10 fold and hit $700 million by 2025. In 2020 alone, they had 55%+ growth of gross margin before being listed on a stock exchange. The 3D printing company currently has 9 different printers and several different softwares. Their capabilities unlocks the range of new applications across 14 proprietary materials. They already have many bluechip customers as well and are actively looking for more. Right now, their TAM (Total Addressable Market) sits at $18 billion. They expect this to reach $118 billion by 2029 as demand and application for 3D printing sharply rises. The company is profitable with $40 million in gross profit for year 2020. This helps remove some of the “speculative” reputation this is associated with SPACs. Markforged forecasts double digit net profit growth for the next 5 years at least. AONE Stock Forecast And Price Targets Markforged president and CEO claimed that Markforged has “been at the forefront of the additive manufacturing industry, and this transaction will enable us to build on our incredible momentum and provide capital and flexibility to grow.” Now might be the perfect time for investors to strike after Markforged has been beaten down these past few months. Moreover, Markforged has been beating out its competitors before even being on the market. Compared to Desktop metals (NYSE: DM), Markforged had over 3 times the revenue. Moreover, Desktop Metals currently sits at a market cap of over $3 billion while Markforged’s merger has a valuation of $2.1 billion. Desktop Metals was as high as a $6 billion market cap, but got recently beaten down due to the rotation away from growth stocks. The market share for Markforged is most certainly available for Markforged to grow into. It’s hard to how long it will take for the momentum for Markforged to start, but it’s safe to say that now is a pretty early time to get in. AONE has largely gone unnoticed, but media attention will quickly snowball for it. SPACs don’t typically fall much below $10 pre-merger and AONE is currently at about $10.10. This represents a pretty low risk high reward opportunity. If anything, AONE could be a decent store of cash at these levels with little downside. My AONE stock forecast is bullish for the long-term. The SPAC might trade sideways for another month or two, but will most likely build momentum before the merger. For the long-term, Markforged could be a great opportunity. 6 Month Price Target: $141 Year Price Target: $183 Year Price Target: $54... Read more...3 SPACS To Buy Now And Double Your Money In 2021May 5, 2022Coming Soon..... Read more...Is MP Materials a Buy?May 5, 2022Coming Soon..... Read more...Clover Health Short Squeeze… The Next Gamestop?May 5, 2022Clover Health falls almost 50% from its all time highs. Increasing short interest raises the question: Will a Clover Health short squeeze occur? Why Clover Health Is Down 50% Just under a year ago, a special acquisition company (SPAC) took Clover Health (NASDAQ: CLOV) public. The SPAC was led by Chamath Palihapitiya who continues to support Clover Health despite it’s weak stock price lately. 3 reasons contribute to Clover Health’s weak price action. The most obvious one is a short report from Hindenburg Research. The short report claims that Chamath’s SPAC and Clover Health were not fully transparent with their investors. It expresses concern over the validity of several claims made by Clover Health and does not see Clover Health growing as they predict to. Directly after the report, Clover Health fired back, disputing many of Hindenburg’s points and helped clarify uncertainty about themselves. You can read their response here. Investors remained wary, despite Clover’s short report rebuttal. Next, SPACs, in general, have been hit hard these past few months. A rotation from growth stocks/SPACs into larger market caps has taken place. Clover Health is no exception to this transition. Lastly, in March, Clover Health told its investors to expect 10,000 to 12,000 new Medicare Advantage enrolled clients by the end of 2021. While this might be a fair amount, many investors of Clover Health felt this number could be higher. A multitude of factors contributed to the current downfall of Clover Health. The stock has been shorted since the Hindenburg Report and that short interest continues to increase. A Clover Health Short Squeeze Possibility Recently, there have been rumors and articles stating that Clover Health’s short interest exceeded 100%. If this were the case, it could turn into another Gamestop (NYSE: GME) situation very quickly. Gamestop was shorted 141% at one point and investors jumped on the opportunity to trigger a short squeeze. With Clover Health, it’s much more likely that short interest is around 35% and the triple digit short interest is a misconception. However, this doesn’t completely rule out a short squeeze. Clover Health’s free float is currently 109 million while their shares outstanding is 406 million. The majority of Clover Health’s shares are locked up by insiders and are unlocked after Clover Health sustains $30 for 90 days. To decrease the available float even more, we have to subtract institutional and longterm investors’ ownership. Institutional ownership owns 48% of this free float and it’s safe to assume that most of them won’t sell during short-term fluctuations. We’ll give them the benefit of the doubt and say that 1/4 of them sell anyways (should a squeeze happen). In the end, this takes 35.5% out of the equation. Next, we have to remember long-term investors of Clover Health have a portion of this float and won’t sell either. It’s guesswork with this number, but let’s lowball and say it’s about 18%. Now we have 53.5% of the available float out of the equation. Clover Health’s Momentum At this point, we are left with about 58 million shares available for trade. Volume for Clover Health on Friday when the stock price went up over 20% was 249 million shares. It’s safe to assume that there was a large amount trading Clover Health who chose to hold and do not plan on selling given the short squeeze rumors. From Friday’s volume, we can assume new investors hold another 15-20%. Of course, at this point it’s all guesswork, but we are only trying to find whether a short squeeze is possible or not. After including the 15-20%, this leaves about 29 million shares available. The short interest represents just short of 40 million shares. Obviously, this isn’t to the degree of the Gamestop situation, but hypothetically, there’s more short interest than available shares. In order for a short squeeze to take place of massive proportions, available shares need to continue to decrease and short interest needs to rise. Moreover, if short interest was 141%, a gargantuan squeeze would be much more likely. Right now, a squeeze of those proportions will not occur, but a squeeze is definitely still on the table. Shorts will need to cover their positions, especially if investors continue to gobble up shares. What You Should Do Overall, Clover Health stock has been completely beaten down. Though, the huge volume Friday shows that there is certainly buzz around Clover Health. This is not a situation where you want to go all-in, but there still could be money to be made. If social sentiment continues to increase for Clover Health, the short interest could escalate. However, Wallstreet will still try to avoid being in the same position as the Gamestop situation. The chances are low, but a squeeze is not also out of the question. Either way, Clover Health stock is still at a discount for the long-term. Chamath called Clover Health: “the greatest growth opportunity” that he’s ever seen. Additionally, Clover Health recently announced some great news. The Center for Medicare and Medicaid Innovation announced that Clover would one of 53 direct contractors that will participate in Medicare and Medicaid’s Global and Professional Direct Contracting Model. Clover will see an increase in future revenue and clients as a result. In conclusion, if you believe in Chamath and the underlying business, then Clover Health is a buy. Any momentum from a possible Clover Health short squeeze should be considered a bonus on top of your conviction.... Read more...How to Invest in the Stock MarketMay 5, 2022Coming Soon..... Read more...
